280 related articles for article (PubMed ID: 12362256)
1. Imiquimod: a review.
Gupta AK; Browne M; Bluhm R
J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
[TBL] [Abstract][Full Text] [Related]
2. Viral and nonviral uses of imiquimod: a review.
Gupta AK; Cherman AM; Tyring SK
J Cutan Med Surg; 2004; 8(5):338-52. PubMed ID: 15868314
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod as an immune response modulator in infectious conditions.
Skinner RB
Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod.
Garland SM
Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
[TBL] [Abstract][Full Text] [Related]
5. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
Carrasco D; vander Straten M; Tyring SK
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod applied topically: A novel immune response modifier.
Tyring S
Skin Therapy Lett; 2001 Mar; 6(6):1-4. PubMed ID: 11298484
[TBL] [Abstract][Full Text] [Related]
7. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
9. Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream.
Schaen L; Mercurio MG
Pediatr Dermatol; 2001; 18(5):450-2. PubMed ID: 11737697
[TBL] [Abstract][Full Text] [Related]
10. Treatment of genital warts with an immune-response modifier (imiquimod).
Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
[TBL] [Abstract][Full Text] [Related]
11. Topical imiquimod: mechanism of action and clinical applications.
Vidal D
Mini Rev Med Chem; 2006 May; 6(5):499-503. PubMed ID: 16719822
[TBL] [Abstract][Full Text] [Related]
12. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
13. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
Moresi JM; Herbert CR; Cohen BA
Pediatr Dermatol; 2001; 18(5):448-50; discussion 452. PubMed ID: 11737696
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of perianal warts in a child with 5% imiquimod cream.
Gruber PC; Wilkinson J
J Dermatolog Treat; 2001 Dec; 12(4):215-7. PubMed ID: 12241631
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod (Aldara): modifying the immune response.
Rudy SJ
Dermatol Nurs; 2002 Aug; 14(4):268-70. PubMed ID: 12240505
[TBL] [Abstract][Full Text] [Related]
16. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
19. Topical imiquimod.
Pearson GW; Langley RG
J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Vexiau D; Decuypère L; Moyse D; Aractingi S
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]